Showing results (211-220 of 503) with videos related to

Sort By:
Pageof 51
Advances in Therapy|September 11, 2019
Correction to: Cardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisMarilyn K Glassberg, Steven D Nathan, Chin-Yu Lin, et al.
Chest|April 1, 1995
Bronchiolitis obliterans in single-lung transplant recipientsS D Nathan, D J Ross, M J Belman, et al.
The American Journal of Pathology|February 10, 2015
Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosisVarvara Kirillov, Jonathan T Siler, Mahalakshmi Ramadass, et al.
Chest|March 10, 2017
The Diagnosis and Management of Airway Complications Following Lung TransplantationAmit K Mahajan, Erik Folch, Sandeep J Khandhar, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|January 10, 2019
Left Ventricular Function Before and After Aerobic Exercise Training in Women With Pulmonary Arterial HypertensionJoshua G Woolstenhulme, Andrew A Guccione, Jeffrey E Herrick, et al.
Journal of Pediatric Surgery|November 11, 2016
The presentation and management of choledochocele (type III choledochal cyst): A 40-year systematic review of the literatureInna N Lobeck, Phylicia Dupree, Richard A Falcone, et al.
Chest|July 17, 2012
Dynamic patient counseling: a novel concept in idiopathic pulmonary fibrosisA Whitney Brown, Oksana A Shlobin, Nargues Weir, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 27, 2025
Improvement in bile drainage after Kasai portoenterostomy with a tailored steroid protocolMuhammed Ali Colak, Shivam Joshi, Christie Heinzman, et al.
BMJ Open Respiratory Research|December 25, 2025
Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosisMartin Kolb, Tamera J Corte, Jeremy Feldman, et al.
Chest|May 24, 2013
Glucose transporter-1 distribution in fibrotic lung disease: association with [¹⁸F]-2-fluoro-2-deoxyglucose-PET scan uptake, inflammation, and neovascularizationSouheil El-Chemaly, Daniela Malide, Jianhua Yao, et al.
Pageof 51